LNA modified phosphorothiolated oligonucleotides

Details for Australian Patent Application No. 2007209481 (hide)

Owner Santaris Pharma A/S

Inventors Orum, Henrik; Koch, Troels; Elmen, Joacim; Hansen, Henrik Frydenlund

Agent FB Rice

Pub. Number AU-B-2007209481

PCT Pub. Number WO2007/085485

Priority 60/762,920 27.01.06 US

Filing date 29 January 2007

Wipo publication date 2 August 2007

Acceptance publication date 12 January 2012

International Classifications

C07H 19/06 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 19/16 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/085485 Priority application(s): WO2007/085485

12 January 2012 Application Accepted

  Published as AU-B-2007209481

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209489-Titanium dioxide pigment particles with doped dense SiO2 skin and method for the production thereof

2007209465-Acyclic sulfamide derivatives